Investigating the Effect of Gatifloxacin in Treatment of Respiratory Tract Infection
Bin Xing
Abstract
Bin Xing
Abstract
Objective:To study the effect of gatifloxacin in treating respiratory tract infections.Methods:A randomized,double-blind clinical design was used in 117 cases to accomplish the clinical trial,in which 61 patients were assigned to therapy group and 56 patients were assigned to control group.Results:The rates of curing,efficacy and bacterial eradication in the therapy group were 60.66%,90.16% and 83.33% in comparison with 53.57%,75%,79.49% in the control group.The rates of efficacy in therapy and control groups were 90.16% and 75% respectively(χ2=4.74 P0.05).Conclusions:The effect of gatifloxacin was exact and gatifloxacin can be used as the first chosen drug in the treatment of respiratory tract infections.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the effect of gatifloxacin in treating respiratory tract infections.Methods:A randomized,double-blind clinical design was used in 117 cases to accomplish the clinical trial,in which 61 patients were assigned to therapy group and 56 patients were assigned to control group.Results:The rates of curing,efficacy and bacterial eradication in the therapy group were 60.66%,90.16% and 83.33% in comparison with 53.57%,75%,79.49% in the control group.The rates of efficacy in therapy and control groups were 90.16% and 75% respectively(χ2=4.74 P0.05).Conclusions:The effect of gatifloxacin was exact and gatifloxacin can be used as the first chosen drug in the treatment of respiratory tract infections.
Key concepts: Gatifloxacin, Medicine, Internal medicine, Respiratory tract infections, Clinical trial, Respiratory tract, Clinical efficacy, Drug